Cargando…
Young onset type 2 diabetic patients might be more sensitive to metformin compared to late onset type 2 diabetic patients
It is unknown whether YOD (young onset diabetes) and LOD (late onset diabetes) require similar insulin doses for intensive insulin therapy with a metformin add-on to achieve glycemic control. We analyzed data from our two previously performed randomized, controlled open-label trials. Patients were r...
Autores principales: | Li, Feng-fei, Liu, Bing-li, Yin, Guo-ping, Zhang, Dan-feng, Zhai, Xiao-fang, Chen, Mao-yuan, Su, Xiao-fei, Wu, Jin-dan, Ye, Lei, Ma, Jian-hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5703958/ https://www.ncbi.nlm.nih.gov/pubmed/29180640 http://dx.doi.org/10.1038/s41598-017-16658-x |
Ejemplares similares
-
Metformin add-on continuous subcutaneous insulin infusion on precise insulin doses in patients with type 2 diabetes
por: Li, Feng-fei, et al.
Publicado: (2018) -
Health consequences of early-onset compared with late-onset type 2 diabetes mellitus
por: Hou, Can, et al.
Publicado: (2022) -
Bodyweight threshold for sudden onset of ketosis might exist in ketosis‐prone type 2 diabetes patients
por: Satomura, Atsushi, et al.
Publicado: (2019) -
Blood Glucagon Levels Predict the Hemoglobin A1c Response to Saxagliptin in Patients with Type 2 Diabetes Inadequately Controlled with Metformin
por: Liu, Hao, et al.
Publicado: (2016) -
Administration of thiamazole for Graves’ disease might trigger the onset of type 1 diabetes
por: Mizutani, Gen, et al.
Publicado: (2018)